Synthetic biology for disease prevention and treatment
Founded in 2022, Esphera SynBio engineers exosomes via synthetic biology for cancer immunotherapies and infectious disease vaccines, based on university IP.
No hay datos disponibles
No hay elementos FAQ disponibles.